Researchers identify a gene that causes excessive androgen production in polycystic ovary syndrome

by Frances Dumenci

Researchers from Penn State College of Medicine and Virginia Commonwealth University School of Medicine have found that a specific protein is increased in theca cells, the source of excess male sex hormones, or androgens, that characterizes polycystic ovary syndrome (PCOS). The results of the study will be published in an upcoming issue of the Proceedings of the National Academy of Sciences (PNAS) as the journal cover article. The paper will be available in this week's online Early Edition.

PCOS is a common disease affecting 7 percent of reproductive-aged women worldwide. Symptoms of PCOS include increased male sex hormone levels, which cause hirsutism and acne; infertility due to the failure to ovulate; and enlarged ovaries with follicle cysts. In addition, obesity and diabetes are often associated with PCOS.

"There is a consensus that theca of are the primary source of excess androgens that characterizes PCOS," said Jan M. McAllister, Ph.D., lead author of the study and professor of pathology and obstetrics and gynecology at Penn State College of Medicine.

Studies conducted over the past decade have built a convincing argument that genetic factors contribute to PCOS. However, despite advances in genetic technologies, few if any PCOS susceptibility genes have been validated. The current study found that an alternative product of the DENND1A gene, DENND1A.V2, is increased in PCOS theca cells.

McAllister noted, "Prior to our studies, there was no pathophysiological link between DENND1A to reproduction or ovarian function. Our observations suggest that DENND1A is involved in a signaling cascade that subsequently results in increased androgen production."

The study showed that raising DENND1A.V2 in normal theca cells increases the expression of genes that lead to elevated androgen production. It also found that silencing DENND1A.V2 in PCOS theca cells reverts them to a normal phenotype.

"Our findings establish that increased DENND1A.V2 expression is sufficient to promote a PCOS phenotype in human theca cells," said Jerome F. Strauss, M.D., Ph.D., senior author of the study and dean of the VCU School of Medicine. "This information can inform development of diagnostic tests for PCOS based on measurements of DENND1A.V2, and may one day lead to novel therapeutic interventions, including drugs or antibodies that neutralize the action of DENND1A.V2."

More information: Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype, www.pnas.org/cgi/doi/10.1073/pnas.1400574111

add to favorites email to friend print save as pdf

Related Stories

Women with PCOS have family heart disease link

Oct 05, 2011

A new study from the University of Adelaide shows the parents of women with polycystic ovary syndrome (PCOS) are more likely to have some form of cardiovascular disease.

New diagnostics for ovarian syndrome

Dec 05, 2013

(Medical Xpress)—Having multiple ovarian follicles is the leading cause of infertility in America, with wider implications for cancer, cardiovascular disease, metabolic syndromes, hormonal imbalance and ...

Recommended for you

Restrictions lifted at British bird flu farm

16 hours ago

Britain on Sunday lifted all restrictions at a duck farm in northern England after last month's outbreak of H5N8 bird flu, the same strain seen in recent cases across Europe.

Recorded Ebola deaths top 7,000

Dec 20, 2014

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

Dec 20, 2014

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.